Results 221 to 230 of about 3,652,623 (306)
Zero-Inflated Promotion Cure-Rate Models With Frailty and Flexible Activation Schemes. [PDF]
Assunção D +5 more
europepmc +1 more source
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic +10 more
wiley +1 more source
A Bayesian Log-Cauchy Mixture Cure Fraction Model for Heavy-Tailed Survival Data: Implementation via OpenBUGS. [PDF]
Salah K.
europepmc +1 more source
The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad +2 more
wiley +1 more source
A novel two-parameter discrete exponentiated exponential distribution with its neutrosophic extension: mathematical characterization and real-world count data modeling. [PDF]
P FA, V S.
europepmc +1 more source
Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen +19 more
wiley +1 more source
Multi-omics network inference with a Gaussian copula model. [PDF]
Tomilina E, Mazo G, Jaffrézic F.
europepmc +1 more source

